Literature DB >> 25036871

Rho GTPases modulate malignant transformation of tumor cells.

Jose L Orgaz1, Cecilia Herraiz1, Victoria Sanz-Moreno1.   

Abstract

Rho GTPases are involved in the acquisition of all the hallmarks of cancer, which comprise 6 biological capabilities acquired during the development of human tumors. The hallmarks include proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis programs, as defined by Hanahan and Weinberg. (1) Controlling these hallmarks are genome instability and inflammation. Emerging hallmarks are reprogramming of energy metabolism and evading immune destruction. To give a different view to the readers, we will not be focusing on invasion, metastasis, or cytoskeletal remodeling, but we will review here how Rho GTPases contribute to other hallmarks of cancer with a special emphasis on malignant transformation.

Entities:  

Keywords:  Rho GTPases; inflammation; metabolism; oncogene; proliferation; senescence; survival; transformation; tumor progression

Mesh:

Substances:

Year:  2014        PMID: 25036871      PMCID: PMC4125382          DOI: 10.4161/sgtp.29019

Source DB:  PubMed          Journal:  Small GTPases        ISSN: 2154-1248


  242 in total

1.  Rho-kinase/ROCK is involved in cytokinesis through the phosphorylation of myosin light chain and not ezrin/radixin/moesin proteins at the cleavage furrow.

Authors:  H Kosako; T Yoshida; F Matsumura; T Ishizaki; S Narumiya; M Inagaki
Journal:  Oncogene       Date:  2000-12-07       Impact factor: 9.867

2.  RhoB is required to mediate apoptosis in neoplastically transformed cells after DNA damage.

Authors:  G J Cerniglia; E J Bernhard; G C Prendergast
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

3.  Generation of rac3 null mutant mice: role of Rac3 in Bcr/Abl-caused lymphoblastic leukemia.

Authors:  Young Jin Cho; Bin Zhang; Vesa Kaartinen; Leena Haataja; Ivan de Curtis; John Groffen; Nora Heisterkamp
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

4.  Overexpression of Rac1 in leukemia patients and its role in leukemia cell migration and growth.

Authors:  Jiying Wang; Qing Rao; Min Wang; Hui Wei; Haiyan Xing; Hang Liu; Yanzhong Wang; Kejing Tang; Leiwen Peng; Zheng Tian; Jianxiang Wang
Journal:  Biochem Biophys Res Commun       Date:  2009-06-27       Impact factor: 3.575

Review 5.  Rho GTPases in transformation and metastasis.

Authors:  Aron B Jaffe; Alan Hall
Journal:  Adv Cancer Res       Date:  2002       Impact factor: 6.242

Review 6.  Selected glimpses into the activation and function of Src kinase.

Authors:  J D Bjorge; A Jakymiw; D J Fujita
Journal:  Oncogene       Date:  2000-11-20       Impact factor: 9.867

7.  An essential role for Rac in Ras transformation.

Authors:  R G Qiu; J Chen; D Kirn; F McCormick; M Symons
Journal:  Nature       Date:  1995-03-30       Impact factor: 49.962

8.  Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer.

Authors:  Takao Kamai; Toshihiko Tsujii; Kyoko Arai; Kentaro Takagi; Hidekazu Asami; Yuji Ito; Hiroyuki Oshima
Journal:  Clin Cancer Res       Date:  2003-07       Impact factor: 12.531

9.  Overexpression of Ras homologous C (RhoC) induces malignant transformation of hepatocytes in vitro and in nude mouse xenografts.

Authors:  Shuli Xie; Mingguang Zhu; Guoyue Lv; Yajun Geng; Guofu Chen; Jian Ma; Guangyi Wang
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

10.  Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters.

Authors:  G Fritz; C Brachetti; F Bahlmann; M Schmidt; B Kaina
Journal:  Br J Cancer       Date:  2002-09-09       Impact factor: 7.640

View more
  74 in total

1.  Chemotherapy Resistance in Diffuse-Type Gastric Adenocarcinoma Is Mediated by RhoA Activation in Cancer Stem-Like Cells.

Authors:  Changhwan Yoon; Soo-Jeong Cho; Bülent Arman Aksoy; Do Joong Park; Nikolaus Schultz; Sandra W Ryeom; Sam S Yoon
Journal:  Clin Cancer Res       Date:  2015-10-19       Impact factor: 12.531

Review 2.  Targeting the RhoGTPase/ROCK pathway for the treatment of VHL/HIF pathway-driven cancers.

Authors:  Jordan M Thompson; Jaime Landman; Olga V Razorenova
Journal:  Small GTPases       Date:  2017-07-07

Review 3.  Inhibition of Cdc42 and Rac1 activities in pheochromocytoma, the adrenal medulla tumor.

Authors:  Pauline Croisé; Laurent Brunaud; Petra Tóth; Stéphane Gasman; Stéphane Ory
Journal:  Small GTPases       Date:  2016-06-29

4.  PtdIns(3,4,5)P3-dependent Rac Exchanger 1 (PREX1) Rac-Guanine Nucleotide Exchange Factor (GEF) Activity Promotes Breast Cancer Cell Proliferation and Tumor Growth via Activation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) Signaling.

Authors:  Heng-Jia Liu; Lisa M Ooms; Nuthasuda Srijakotre; Joey Man; Jessica Vieusseux; JoAnne E Waters; Yue Feng; Charles G Bailey; John E J Rasko; John T Price; Christina A Mitchell
Journal:  J Biol Chem       Date:  2016-06-29       Impact factor: 5.157

Review 5.  Mechano-reciprocity is maintained between physiological boundaries by tuning signal flux through the Rho-associated protein kinase.

Authors:  Sarah T Boyle; Michael S Samuel
Journal:  Small GTPases       Date:  2016-05-11

6.  Rho GTPases at the crossroad of signaling networks in mammals.

Authors:  Jean Claude Hervé; Nicolas Bourmeyster
Journal:  Small GTPases       Date:  2015-06-25

7.  High Expression of Cell Division Cycle 42 Promotes Pancreatic Cancer Growth and Predicts Poor Outcome of Pancreatic Cancer Patients.

Authors:  Dejun Yang; Yu Zhang; Yajun Cheng; Liang Hong; Changming Wang; Ziran Wei; Qingping Cai; Ronglin Yan
Journal:  Dig Dis Sci       Date:  2017-02-08       Impact factor: 3.199

Review 8.  The Rho GTPase signalling pathway in urothelial carcinoma.

Authors:  Solomon L Woldu; Ryan C Hutchinson; Laura-Maria Krabbe; Oner Sanli; Vitaly Margulis
Journal:  Nat Rev Urol       Date:  2017-11-14       Impact factor: 14.432

Review 9.  Dynamic interplay between adhesion surfaces in carcinomas: Cell-cell and cell-matrix crosstalk.

Authors:  Yvonne E Smith; Sri HariKrishna Vellanki; Ann M Hopkins
Journal:  World J Biol Chem       Date:  2016-02-26

10.  Therapeutic Potential of Focal Adhesion Kinase Inhibition in Small Cell Lung Cancer.

Authors:  Frank Aboubakar Nana; Marylène Lecocq; Maha Zohra Ladjemi; Bruno Detry; Sébastien Dupasquier; Olivier Feron; Pierre P Massion; Yves Sibille; Charles Pilette; Sebahat Ocak
Journal:  Mol Cancer Ther       Date:  2018-10-23       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.